Association of Adiponectin 45T/G (rs2241766) and Visfatin 4689G/T (rs2110385) Gene Polymorphisms with Susceptibility to Obesity

Foad Ghazizadeh, Sepideh Afshari ‑Moez, Nazila Alinaghian, Mansour Torab, Parvaneh Rahimi‑ Moghaddam

Abstract


Background: This study aimed to see whether the adiponectin 45T/G (rs2241766) and visfatin 4689G/T (rs2110385) gene polymorphisms in an Iranian population are linked to obesity and/ or obesity‑related traits in normal and obese individuals. Methods: 230 obese individuals and 169 healthy controls had their genomic DNA taken. The alleles and genotypes of the rs2241766 and rs2110385 polymorphisms were determined using the polymerase chain reaction‑restriction fragment length polymorphism (PCR-RFLP) technique. Results: Obese individuals had considerably greater frequencies of the G allele and GG genotypes of the rs2241766 polymorphism than healthy controls (35% vs 21%, Probability (P) <0.0001, odds ratios (OR): 1.99, 95% confidence intervals (CI): 1.45–2.75 and 21% vs 7%, P = 0.002, OR: 3.52, 95% CI: 1.81–6.85, respectively). In comparison to healthy controls, obesity patients had substantially lower frequencies of the T allele and TT genotype of the rs2241766 polymorphism (65% vs 79%, P < 0.0001, OR: 0.50, 95% CI: 0.36–0.69 and 51% vs 65%, P = 0.008, OR: 0.58, 95% CI: 0.39–0.87, respectively). Obese individuals had substantially higher frequencies of the G allele and GG genotype in the rs2110385 polymorphism than healthy controls (77% vs 69%, P = 0.01, OR: 1.47, 95% CI: 1.07– 2.0 and 61% versus 51%, P = 0.047, OR: 1.5, 95% CI: 1.0–2.2, respectively). When compared to healthy controls, the frequency of the T allele in the rs2110385 polymorphism was considerably lower in obese individuals (23% vs 31%, P = 0.01, OR: 0.68, 95% CI: 0.5–0.93). Furthermore, these single nucleotide polymorphisms (SNPs) were shown to have a strong link to clinical data in obese individuals. In the case of adiponectin, 45T/G (rs2241766) genotypes, serum low‑density lipoprotein, waist circumference, and diastolic blood pressure were substantially different among the rs2241766 genotypes (P = 0.007, P = 0.000, and P = 0.011, respectively). In the instance of the visfatin 4689G/T (rs2110385) gene polymorphism, serum triglycerides was substantially different among the rs2110385 genotypes (P = 0.039). Conclusions: In the Iranian population, our findings revealed a strong link between adiponectin and visfatin gene polymorphisms and obesity and several obesity‑related clinical characteristics. These SNPs might be used to identify those who are at risk of becoming obese.

International Journal of Preventive Medicine 14(1):115, September 2023. | DOI: 10.4103/ijpvm.ijpvm_79_22

 

Corresponding Author: Dr. Parvaneh Rahimi‑Moghaddam,

E-mail: rahimi.p@iums.ac.ir

You can also search for this author in: PubMed  Google Scholar

 


Keywords


Adiponectin; obesity; polymorphism; visfatin

Full Text:

PDF

References


Rodgers A, Woodward A, Swinburn B, Dietz WH. Prevalence

trends tell us what did not precipitate the US obesity epidemic.

Lancet Public Health 2018;3:e162‑3.

Fasshauer M, Blüher M. Adipokines in health and disease.

Trends Pharmacol Sci 2015;36:461‑70.

Dahlman I, Arner P. Obesity and polymorphisms in

genes regulating human adipose tissue. Int J Obes (Lond)

;31:1629‑41.

Wu J, Liu Z, Meng K, Zhang L. Association of adiponectin

gene (ADIPOQ) rs2241766 polymorphism with obesity in adults:

A meta‑analysis. PLoS One 2014;9:e95270.

Lim J, Park HS, Kim J, Jang YJ, Kim JH, Lee Y, et al.

Depot‑specific UCP1 expression in human white adipose

tissue and its association with obesity‑related markers. Int J

Obes (Lond) 2020;44:697‑706.

Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, et al.

Genetic variation in the gene encoding adiponectin is associated

with an increased risk of type 2 diabetes in the Japanese

population. Diabetes 2002;51:536‑40.

Han L, Wu Q, Jiao M, Hao Y, Liang L, Gao L, et al. Associations

between single‑nucleotide polymorphisms (+45T>G,+276G>T,−1

C>G,−11391G>A) of adiponectin gene and type 2 diabetes

mellitus: A systematic review and meta‑analysis. Diabetologia

;54:2303‑14.

Beckers S, Peeters AV, De Freitas F, Mertens IL, Verhulst SL,

Haentjens D, et al. Association study and mutation analysis of

adiponectin shows association of variants in APM1 with complex

obesity in women. Ann Hum Genet 2009;73:492‑501.

Chen X, Li X, Lin X, Gao H, Li Q, Zha J. Association of single

nucleotide polymorphism at position 45 in adiponectin gene with

plasma adiponectin level and insulin resistance in obesity. Int J

Rad Med Nucl Med 2012;36:269‑73.

Ukkola O, Ravussin E, Jacobson P, Sjöström L, Bouchard C.

Mutations in the adiponectin gene in lean and obese subjects from

the Swedish obese subjects cohort. Metabolism 2003;52:881‑4.

Nourbakhsh M, Nourbakhsh M, Gholinejad Z, Razzaghy‑Azar M.

Visfatin in obese children and adolescents and its association

with insulin resistance and metabolic syndrome. Scand J Clin

Lab Invest 2015;75:183‑8.

Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M,

Kishimoto K, et al. Visfatin: A protein secreted by visceral fat

that mimics the effects of insulin. Science 2005;307:426‑30.

Lakka TA, Rankinen T, Weisnagel SJ, Chagnon YC, Rice T,

Leon AS, et al. A quantitative trait locus on 7q31 for the

changes in plasma insulin in response to exercise training: The

HERITAGE Family Study. Diabetes 2003;52:1583‑7.

Arya R, Blangero J, Williams K, Almasy L, Dyer TD, Leach RJ,

et al. Factors of insulin resistance syndrome–related phenotypes

are linked to genetic locations on chromosomes 6 and 7 in

nondiabetic Mexican‑Americans. Diabetes 2002;51:841‑7.

Wu X, Cooper RS, Borecki I, Hanis C, Bray M, Lewis CE,

et al. A combined analysis of genomewide linkage scans for

body mass index, from the National Heart, Lung, and Blood

Institute Family Blood Pressure Program. Am J Hum Genet

;70:1247‑56.

Wharton S, Lau DC, Vallis M, Sharma AM, Biertho L,

Campbell‑Scherer D, et al. Obesity in adults: A clinical practice

guideline. CMAJ 2020;192:E875‑91.

Namvaran F, Rahimi‑Moghaddam P, Azarpira N,

Dabbaghmanesh MH. Polymorphism of adiponectin (45T/G)

and adiponectin receptor‑2 (795G/A) in an Iranian population:

Relation with insulin resistance and response to treatment with

pioglitazone in patients with type 2 diabetes mellitus. Mol Biol

Rep 2012;39:5511‑8.

Potapov VA, Chistiakov DA, Dubinina A, Shamkhalova MS,

Shestakova MV, Nosikov VV. Adiponectin and adiponectin

receptor gene variants in relation to type 2 diabetes and insulin

resistance‑related phenotypes. Rev Diabet Stud 2008;5:28‑37.

Bailey SD, Loredo‑Osti JC, Lepage P, Faith J, Fontaine J,

Desbiens KM, et al. Common polymorphisms in the promoter

of the visfatin gene (PBEF1) influence plasma insulin levels in a

French‑Canadian population. Diabetes 2006;55:2896‑902.

Ji MJ, Ku EJ, Oh TK, Jeon HJ. Association of adiponectin

T/G polymorphism with diabetic cardiovascular complications

in Korean type 2 diabetes. J Korean Med Sci 2018;33:e124.

Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W,

Weisser M, et al. Association of the TG polymorphism in

adiponectin (exon 2) with obesity and insulin sensitivity:

Interaction with family history of type 2 diabetes. Diabetes

;51:37‑41.

Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH,

Scherer PE, et al. A haplotype at the adiponectin locus is

associated with obesity and other features of the insulin

resistance syndrome. Diabetes 2002;51:2306‑12.

Javanmard SH, Dehghananzadeh R, Rafiee L, Naji H, Rezayat A,

Sarrafzadegan N. Genetic associations of the visfatin G‑948T

polymorphism with obesity‑related metabolic traits in an Iranian

population. J Res Med Sci 2016;21:105.